Sign inGet started

You Angie

Insider CIK 1647664 · DNAI Chief Bus. & Strat. Officer · ORIC Director · RYZB Director · ATTO Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ATTO Attovia Therapeutics, Inc. A Award deriv2026-08-042026-08-0627,000— $027,000SEC↗
ATTO Attovia Therapeutics, Inc. A Award deriv2026-08-042026-08-0627,000— $027,000SEC↗
ORIC Oric Pharmaceuticals, Inc. A Award deriv2026-01-022026-01-0640,000— $040,000SEC↗
ORIC Oric Pharmaceuticals, Inc. P Buy2025-06-232025-06-231,403$9.43 $13.2K28,000SEC↗
ORIC Oric Pharmaceuticals, Inc. P Buy2025-06-202025-06-2326,597$9.39 $249.7K26,597SEC↗
ORIC Oric Pharmaceuticals, Inc. A Award deriv2025-01-022025-01-0635,000— $035,000SEC↗
ORIC Oric Pharmaceuticals, Inc. A Award deriv2024-06-122024-06-1425,600— $025,600SEC↗
RYZB RayzeBio, Inc. D To issuer deriv2024-02-262024-02-2740,848— $00SEC↗
RYZB RayzeBio, Inc. D To issuer deriv2024-02-262024-02-2773,731— $00SEC↗
ORIC Oric Pharmaceuticals, Inc. A Award deriv2023-06-142023-06-1520,500— $020,500SEC↗
ORIC Oric Pharmaceuticals, Inc. A Award deriv2022-06-172022-06-1745,158— $045,158SEC↗
ORIC Oric Pharmaceuticals, Inc. A Award deriv2021-11-092021-11-1033,250— $033,250SEC↗
SRRA Sierra Oncology, Inc. A Award deriv2018-03-062018-03-07180,360— $0180,360SEC↗
SRRA Sierra Oncology, Inc. P Buy2017-03-082017-03-0930,000$1.43 $42.9K133,252SEC↗
SRRA Sierra Oncology, Inc. A Award deriv2017-03-062017-03-0870,000— $070,000SEC↗
DNAI ProNAi Therapeutics Inc A Award deriv2016-09-302016-10-04200,000— $0200,000SEC↗
DNAI ProNAi Therapeutics Inc A Award deriv2016-03-082016-03-1075,000— $075,000SEC↗